Identification of a Hierarchy of Multipotent Hematopoietic Progenitors in Human Cord Blood

Cell Stem Cell

Volumn 1, Issue 6, 2007, Pages 635-645

  Majeti, Ravindra ^a,b   Park, Christopher Y ^a,b   Weissman, Irving L ^a,b  

^a STANFORD UNIVERSITY   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

STEMCELL

Indexed keywords

CD34 ANTIGEN; CD38 ANTIGEN; CD45RA ANTIGEN; THY 1 ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; BONE MARROW; CELL POPULATION; CELL SELECTION; CELL SUBPOPULATION; CONTROLLED STUDY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MULTIPOTENT STEM CELL; NONHUMAN; PRIORITY JOURNAL; UMBILICAL CORD BLOOD; XENOTRANSPLANTATION;

ANTIGENS, CD45; ANTIGENS, THY-1; CELL PROLIFERATION; CELL SEPARATION; FETAL BLOOD; HEMATOPOIETIC STEM CELLS; HUMANS; MULTIPOTENT STEM CELLS;

EID: 36749098400     PISSN: 19345909     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.stem.2007.10.001     Document Type: Article

References (32)

1. Baum C.M., Weissman I.L., Tsukamoto A.S., Buckle A.M., and Peault B. Isolation of a candidate human hematopoietic stem-cell population. Proc. Natl. Acad. Sci. USA 89 (1992) 2804-2808
2. Bhatia M., Wang J.C., Kapp U., Bonnet D., and Dick J.E. Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. Proc. Natl. Acad. Sci. USA 94 (1997) 5320-5325
3. Blair A., Hogge D.E., Ailles L.E., Lansdorp P.M., and Sutherland H.J. Lack of expression of Thy-1 (CD90) on acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo. Blood 89 (1997) 3104-3112
4. Bonnet D., and Dick J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 3 (1997) 730-737
5. Bryder D., Rossi D.J., and Weissman I.L. Hematopoietic stem cells: The paradigmatic tissue-specific stem cell. Am. J. Pathol. 169 (2006) 338-346
6. Cashman J.D., Lapidot T., Wang J.C., Doedens M., Shultz L.D., Lansdorp P., Dick J.E., and Eaves C.J. Kinetic evidence of the regeneration of multilineage hematopoiesis from primitive cells in normal human bone marrow transplanted into immunodeficient mice. Blood 89 (1997) 4307-4316
7. Christensen J.L., and Weissman I.L. Flk-2 is a marker in hematopoietic stem cell differentiation: A simple method to isolate long-term stem cells. Proc. Natl. Acad. Sci. USA 98 (2001) 14541-14546
8. Craig W., Kay R., Cutler R.L., and Lansdorp P.M. Expression of Thy-1 on human hematopoietic progenitor cells. J. Exp. Med. 177 (1993) 1331-1342
9. Dick J.E., Guenechea G., Gan O.I., and Dorrell C. In vivo dynamics of human stem cell repopulation in NOD/SCID mice. Ann. N Y Acad. Sci. 938 (2001) 184-190
10. Guenechea G., Gan O.I., Dorrell C., and Dick J.E. Distinct classes of human stem cells that differ in proliferative and self-renewal potential. Nat. Immunol. 2 (2001) 75-82
11. Hogan C.J., Shpall E.J., and Keller G. Differential long-term and multilineage engraftment potential from subfractions of human CD34+ cord blood cells transplanted into NOD/SCID mice. Proc. Natl. Acad. Sci. USA 99 (2002) 413-418
12. Ishikawa F., Yasukawa M., Lyons B., Yoshida S., Miyamoto T., Yoshimoto G., Watanabe T., Akashi K., Shultz L.D., and Harada M. Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice. Blood 106 (2005) 1565-1573
13. Jamieson C.H., Ailles L.E., Dylla S.J., Muijtjens M., Jones C., Zehnder J.L., Gotlib J., Li K., Manz M.G., Keating A., et al. Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N. Engl. J. Med. 351 (2004) 657-667
14. Kiel M.J., Yilmaz O.H., Iwashita T., Yilmaz O.H., Terhorst C., and Morrison S.J. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 121 (2005) 1109-1121
15. Kondo M., Wagers A.J., Manz M.G., Prohaska S.S., Scherer D.C., Beilhack G.F., Shizuru J.A., and Weissman I.L. Biology of hematopoietic stem cells and progenitors: Implications for clinical application. Annu. Rev. Immunol. 21 (2003) 759-806
16. Lapidot T., Sirard C., Vormoor J., Murdoch B., Hoang T., Caceres-Cortes J., Minden M., Paterson B., Caligiuri M.A., and Dick J.E. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367 (1994) 645-648
17. Mazurier F., Gan O.I., McKenzie J.L., Doedens M., and Dick J.E. Lentivector-mediated clonal tracking reveals intrinsic heterogeneity in the human hematopoietic stem cell compartment and culture-induced stem cell impairment. Blood 103 (2004) 545-552
18. McCune J.M., Namikawa R., Kaneshima H., Shultz L.D., Lieberman M., and Weissman I.L. The SCID-hu mouse: Murine model for the analysis of human hematolymphoid differentiation and function. Science 241 (1988) 1632-1639
19. McKenzie J.L., Gan O.I., Doedens M., Wang J.C., and Dick J.E. Individual stem cells with highly variable proliferation and self-renewal properties comprise the human hematopoietic stem cell compartment. Nat. Immunol. 7 (2006) 1225-1233
20. Michallet M., Philip T., Philip I., Godinot H., Sebban C., Salles G., Thiebaut A., Biron P., Lopez F., Mazars P., et al. Transplantation with selected autologous peripheral blood CD34+Thy1+ hematopoietic stem cells (HSCs) in multiple myeloma: Impact of HSC dose on engraftment, safety, and immune reconstitution. Exp. Hematol. 28 (2000) 858-870
21. Miyamoto T., Weissman I.L., and Akashi K. AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation. Proc. Natl. Acad. Sci. USA 97 (2000) 7521-7526
22. Morrison S.J., Wandycz A.M., Hemmati H.D., Wright D.E., and Weissman I.L. Identification of a lineage of multipotent hematopoietic progenitors. Development 124 (1997) 1929-1939
23. Morrison S.J., and Weissman I.L. The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype. Immunity 1 (1994) 661-673
24. Murray L., Chen B., Galy A., Chen S., Tushinski R., Uchida N., Negrin R., Tricot G., Jagannath S., Vesole D., et al. Enrichment of human hematopoietic stem cell activity in the CD34+Thy-1+Lin- subpopulation from mobilized peripheral blood. Blood 85 (1995) 368-378
25. Negrin R.S., Atkinson K., Leemhuis T., Hanania E., Juttner C., Tierney K., Hu W.W., Johnston L.J., Shizurn J.A., Stockerl-Goldstein K.E., et al. Transplantation of highly purified CD34+Thy-1+ hematopoietic stem cells in patients with metastatic breast cancer. Biol. Blood Marrow Transplant. 6 (2000) 262-271
26. Peault B., Weissman I., and Baum C. Analysis of candidate human blood stem cells in "humanized" immune-deficiency SCID mice. Leukemia 7 Suppl 2 (1993) S98-S101
27. Shultz L.D., Lyons B.L., Burzenski L.M., Gott B., Chen X., Chaleff S., Kotb M., Gillies S.D., King M., Mangada J., et al. Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells. J. Immunol. 174 (2005) 6477-6489
28. Spangrude G.J., Heimfeld S., and Weissman I.L. Purification and characterization of mouse hematopoietic stem cells. Science 241 (1988) 58-62
29. Sutherland H.J., Eaves C.J., Eaves A.C., Dragowska W., and Lansdorp P.M. Characterization and partial purification of human marrow cells capable of initiating long-term hematopoiesis in vitro. Blood 74 (1989) 1563-1570
30. Tan B.T., Park C.Y., Ailles L.E., and Weissman I.L. The cancer stem cell hypothesis: A work in progress. Lab. Invest. 86 (2006) 1203-1207
31. Vose J.M., Bierman P.J., Lynch J.C., Atkinson K., Juttner C., Hanania C.E., Bociek G., and Armitage J.O. Transplantation of highly purified CD34+Thy-1+ hematopoietic stem cells in patients with recurrent indolent non-Hodgkin's lymphoma. Biol. Blood Marrow Transplant. 7 (2001) 680-687
32. Wang J.C., and Dick J.E. Cancer stem cells: Lessons from leukemia. Trends Cell Biol. 15 (2005) 494-501